GLP-1 Weight Loss Telehealth in California

California is home to roughly 38.9 million people, and about 26.8% of Californiaadults have obesity. Whether treatment is appropriate for any individual is a licensed physician's decision; access should not depend on long waits or expensive in-person visits.

Cities like Los Angeles, San Diego, San Francisco have great healthcare networks, but obesity-medicine specialists often have months-long waitlists. Telehealth bridges that gap. From your home anywhere in California, you can complete a medical assessment and be reviewed by a CA-licensed physician, without an office visit, once we open.

California telehealth rules: California has comprehensive telehealth parity laws and supports asynchronous and video consultations. California-licensed physicians can prescribe compounded GLP-1 medications dispensed by state-licensed pharmacies.

California does not offer a telemedicine license, a telehealth registration, or any other telehealth credential that lets a physician licensed elsewhere treat patients here. It has one rule, and the Medical Board of California states it in a single sentence on its own telehealth page: **physicians using telehealth technologies to provide care to patients located in California must be licensed in California.** The statutory authority is Business and Professions Code section 2052, which makes it a public offense to practice "any system or mode of treating the sick or afflicted in this state", or to diagnose, treat, or prescribe for any ailment of any person, without "a valid, unrevoked, or unsuspended certificate". What controls is where you are sitting, not where the physician is. The Board is explicit that the doctor need not live here: "Physicians need not reside in California, as long as they have a valid, current California license." The exceptions are narrow enough to prove the rule. Section 2060 exempts an out-of-state practitioner who is in "actual consultation" with a California-licensed practitioner, then forbids precisely what a direct-to-patient practice does: that practitioner "shall not open an office, appoint a place to meet patients, receive calls from patients within the limits of this state, give orders, or have ultimate authority over the care or primary diagnosis of a patient who is located within this state." The only telehealth-specific exemption in the Medical Practice Act is section 2052.5, effective January 1, 2024, and it reaches one situation: an eligible out-of-state physician may treat a Californian by telehealth when that patient has "an immediately life-threatening disease or condition" and either was not accepted into the clinical trial nearest home within a week of applying or, in a physician's judgment, cannot reasonably take part in it given the stage of the disease. Weight management is not that situation. The other exemptions in that article reach different ground entirely, such as emergency service and physicians traveling with a sports team or an Olympic delegation, none of them a route to routine care delivered by screen. For ordinary care, a California license is the entire answer. Section 2290.5, as amended effective January 1, 2026, codifies the consent step. Before telehealth care is delivered, the provider initiating it "shall inform the patient about the use of telehealth and obtain verbal or written consent from the patient", and "the consent shall be documented." Subsection (d) supplies the teeth: "The failure of a health care provider to comply with this section shall constitute unprofessional conduct." Read that carefully. The violation is not that the care went wrong. Skipping the conversation, or skipping the note in the chart, is by itself a disciplinable act. Subsection (c) adds the part patients most want to hear: the section "does not preclude a patient from receiving in-person health care delivery services during a specified course of health care and treatment" after the patient has agreed to telehealth. The definition is broad. Section 2290.5(a)(6) defines telehealth as "the mode of delivering health care services and public health via information and communication technologies", and says it "includes synchronous interactions and asynchronous store and forward transfers." Note what is absent: the definition names no excluded technology at all. California puts the weight on conduct instead. Subsection (g) provides that "all laws and regulations governing professional responsibility, unprofessional conduct, and standards of practice" that apply under a provider's license "shall apply to that health care provider while providing telehealth services." California did not write a lighter rulebook for the screen. It applied the existing one. Prescribing is where California surprises people. The widely repeated belief is that the state demands an in-person visit, or at least live video, before a prescription may be written. Section 2242 says something different in plain words. Prescribing, dispensing, or furnishing dangerous drugs "without an appropriate prior examination and a medical indication" is unprofessional conduct, and then: "An appropriate prior examination does not require a synchronous interaction between the patient and the licensee and can be achieved through the use of telehealth, including, but not limited to, a self-screening tool or a questionnaire, provided that the licensee complies with the appropriate standard of care." That closing clause is not decoration, it is the whole test. The statute permits an intake questionnaire as the **format** of the examination. It does not promise the questionnaire will be sufficient in any particular case, and the Medical Board closes the gap: "The standard of care is the same whether the patient is seen in-person, through telehealth or other methods of electronically enabled health care." A form is a permitted format, never a substitute for a physician's judgment, and a licensed physician remains free to ask for more, or to decline to prescribe. One more piece governs anything a pharmacy mails into California. A pharmacy outside the state that ships prescription drugs to a California address is a "nonresident pharmacy" under section 4112 and must be licensed by the California State Board of Pharmacy. A rewritten version of that section replaced the older text on July 1, 2026, and it added a requirement the old version did not carry: the pharmacy must "identify a California-licensed pharmacist employed and working at the nonresident pharmacy to be proposed to serve as the pharmacist-in-charge," and it may not let a pharmacist dispense to California patients if "the pharmacist-in-charge of the pharmacy is not licensed in California." The same section requires a toll-free telephone service, at least six days and 40 hours a week, connecting patients in this state with a pharmacist who has access to the patient's records, and that number must appear on a label affixed to each container dispensed here. California also declined to make mail-order harder in the obvious way: the Board "shall not adopt any regulations that require face-to-face consultation for a prescription that is shipped, mailed, or delivered to the patient."

You can verify any physician's California license at the Medical Board of California.